Company intelligence / Profile preview

Cutera

Brisbane, California, United Statescutera.com ↗

Ownership: Public · CUTR
Employees: ~633
Development stage: Commercial

Overview

Cutera’s devices are FDA-cleared and widely used in dermatology/aesthetic practices globally for non-invasive procedures such as laser hair removal, vascular/pigment lesion treatment, skin revitalization/tightening. The company continues to launch new platforms like xeo+ with improved features for faster treatments and broader applications.

Therapeutic areas: CardiovascularDermatologyMetabolic Disorders
Modalities: Device (Laser-based)Device (Light-based)Device (Radiofrequency energy-based)
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

AviClear

Commercial

Indications: Acne

2 more assets in the full pipeline.

Request access →

Financials

Market cap: $2M
Total revenue: $32.5M
Enterprise value: $376.5M

Beyond the preview

Go deeper on Cutera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutera.

Explore the full profile